-
Dec 11, 2024 | 
rte.ie | Lisa Carey |Margaret Flood
By Margaret Flood, Maynooth University and Lisa Carey, Kennedy Kreiger InstituteDid you know that approximately are diagnosed with cancer each year globally? In Ireland around 191 children under 15 and 70 adolescents aged 15-19 are diagnosed with cancer annually. With a national survival rate of 81%, many of these children and adolescents live long, fulfilling lives after treatment. But returning to school during and after cancer can present unique and ongoing challenges.
-
Dec 4, 2024 | 
centredaily.com | Lisa Carey
While many organizations provide supplies to schools at the beginning of the school year, most of them are gone by January. RoseLife_Family // Shutterstock Altrusa International of Centre County is committed to doing all we can to positively impact literacy. We are holding our second annual Mid-Year Madness where we provide school supplies, clothing, books and other items to two schools in Centre County (Bellefonte and Wingate elementary schools).
-
Aug 20, 2024 | 
nature.com | Daniel G. Stover |Roberto Salgado |Sherene Loi |W. Fraser Symmans |Charles M. Perou |Lisa Carey
AbstractAssociation of stromal tumor-infiltrating lymphocytes (sTILs) with survival outcomes among patients with metastatic breast cancer (MBC) remains unclear. The primary objective was to evaluate the association of sTILs with progression-free survival in randomized phase III trial CALGB 40502.
-
Jul 8, 2024 | 
nature.com | Sara A. Hurvitz |Kevin Kalinsky |Lisa Carey |Hope Rugo |Véronique Diéras
Correction to: npj Breast Cancer https://doi.org/10.1038/s41523-024-00635-5, published online 25 April 2024In Table 1 of this article, the ITT column had some incorrect values. These values have now been replaced with the correct values.
-
Jul 8, 2024 | 
ireland-live.ie | Lisa Carey
Click NEXT or on the arrows above to see next picture WOMEN’S Shed Limerick recently hosted a highly successful fundraiser table quiz, bringing together the community for a night filled with laughter. RTE comedian Bernard O’Shea joined the evening, Monster Fundraiser, as quiz master, and his humour and energy kept everyone entertained throughout the night.
-
Jul 8, 2024 | 
limerickleader.ie | Lisa Carey
Please allow ads as they help fund our trusted local news content.
Kindly add us to your ad blocker whitelist.
If you want further access to Ireland's best local journalism, consider contributing and/or subscribing to our free daily Newsletter .
Support our mission and join our community now.
-
Jun 5, 2024 | 
nature.com | Hope Rugo |Kevin Punie |Aditya Bardia |Sara A. Hurvitz |Javier Cortés |Véronique Diéras | +2 more
Correction to: npj Breast Cancer (2022) 8:98; https://doi.org/10.1038/s41523-022-00467-1, published online 29 August 2022The article includes two typographical errors, on pages 5 and 6. On page 5, in the sentence beginning with “Dose interruptions…”, and on page 6, in the sentence beginning with “A higher frequency…”, the order of the percentage of patients in the SG and TPC arms who discontinued treatment due to adverse events in the ASCENT trial has been written backwards.
-
Apr 24, 2024 | 
nature.com | Sara A. Hurvitz |Kevin Kalinsky |Lisa Carey |Hope Rugo |Véronique Diéras
AbstractIn this post hoc analysis of the ASCENT study, we compared outcomes with sacituzumab govitecan (SG) vs single-agent chemotherapy in clinically important subgroups of patients with metastatic triple-negative breast cancer (mTNBC). Patients with mTNBC refractory to/relapsing after ≥2 prior chemotherapies (≥1 in the metastatic setting) were randomized 1:1 to receive SG or treatment of physician’s choice (TPC) until unacceptable toxicity/progression.
-
Apr 8, 2024 | 
nature.com | Christine Desmedt |Lisa Carey
Metastatic cancer represents the main cause of death in patients with cancer. However, basic and translational research is hampered by the limited availability of metastatic samples. In this context, post-mortem tissue donation programmes represent a complementary and attractive solution. Here, we highlight the opportunities and challenges, and outline why we believe this represents a global effort.
-
Nov 13, 2023 | 
mdedge.com | Lisa Carey
Developments in early breast cancer reported at the European Society for Medical Oncology (ESMO) 2023 Congress are discussed by Dr Lisa Carey of University of North Carolina, Chapel Hill. Dr Carey begins with 5-year results from the KEYNOTE-522 study in patients with early triple-negative breast cancer in which the immune checkpoint inhibitor pembrolizumab was incorporated into combination therapy both pre- and postoperatively.
